Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of the anti-HIV drug tenofovir
disoproxil fumarate (TDF) on lipid levels in HIV infected adults on stable anti-HIV drug
therapy.
Study hypothesis: The addition of TDF to stable background antiretroviral therapy in HIV
infected individuals with dyslipidemia will result in a reduction of non-HDL after 12 weeks
of treatment.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)